| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/09/2005 | CN1592743A Inhibitors of glycogen synthase kinase 3 |
| 03/09/2005 | CN1592645A Combination therapy for treatment of autoimmune diseases using B cell depleting/immunoregulatory anti-body combination |
| 03/09/2005 | CN1592638A Promoters exhibiting endothelial cell specificity and methods of using same |
| 03/09/2005 | CN1592636A Immunotherapeutic combinations for the treatment of tumors |
| 03/09/2005 | CN1592626A Homeostasis-maintaining agents |
| 03/09/2005 | CN1592624A Substituted-triazolopyrimidines as anticancer agents |
| 03/09/2005 | CN1592607A Compositions and methods for delivery of poorly water soluble drugs and methods of treatment |
| 03/09/2005 | CN1590554A Ketone compound and its preparation method and application |
| 03/09/2005 | CN1590408A Preparation technology of globe fish peptide and its medical health care use |
| 03/09/2005 | CN1590386A Sidechain-bearing taxanes and method for the preparation thereof |
| 03/09/2005 | CN1590379A New heterocyclic oxime compounds, preparing process and medical composition thereof |
| 03/09/2005 | CN1589908A Tenascin-C nucleic acid ligands |
| 03/09/2005 | CN1589902A Application of anti-lymphotoxin-beta receptor antibodies in preparation of medical composition |
| 03/09/2005 | CN1589900A Medical health protection use of globe fish glue |
| 03/09/2005 | CN1589872A Red date extract for treating alimentary malignant tumour |
| 03/09/2005 | CN1589861A Danshen capsule for antitumour and its preparation technology |
| 03/09/2005 | CN1589829A Medicine for anticancer, anti-inflammation, calm panting |
| 03/09/2005 | CN1589816A Disinfactant tumour decomposition powder |
| 03/09/2005 | CN1589805A Composition for treating tumour |
| 03/09/2005 | CN1589800A Application of ursolic acid in preparation of tumour cell wither inductor |
| 03/09/2005 | CN1589799A Application of ursolic acid in prepartation of anticancer medicine |
| 03/09/2005 | CN1589798A Suppository for treating cancer pain and its preparation method |
| 03/09/2005 | CN1589778A Microencapsulated saccharomyces and its application |
| 03/09/2005 | CN1589777A Microencapsulated saccharomyces and its application |
| 03/09/2005 | CN1589776A Microencapsulated saccharomyces and its application |
| 03/09/2005 | CN1192105C A variant of C6 beta-chemokine leukotactin-1(shLKn-1) with enhanced biological activity |
| 03/09/2005 | CN1192102C Enzyme catalyzed therapeutic agents |
| 03/09/2005 | CN1192099C Fermented vegetal material, its preparing process and use, and medical composition food additives containing the material |
| 03/09/2005 | CN1192098C Bio-active substance of antrodia camphorata mycelia, its preparing process and its composition |
| 03/09/2005 | CN1192031C Epothilones derivatives, their synthesis and uses |
| 03/09/2005 | CN1191863C Formulations for protection of PEG-alpha interferon conjugates |
| 03/09/2005 | CN1191859C Docetaxel in combination with rhumab HER2 monoclone antibody for treatment of cancers |
| 03/09/2005 | CN1191858C Method for inhibiting brain tnmor growth |
| 03/09/2005 | CN1191857C potentiation of anti-CD38-immunotoxin cytotoxicity |
| 03/09/2005 | CN1191855C Remedies for lymphocytic tumors |
| 03/09/2005 | CN1191854C Model membrane systems |
| 03/09/2005 | CN1191850C Treatment of hemoatological malignancies associated with circulating tumor cells using chimeric anti -CD20 antibody |
| 03/09/2005 | CN1191829C Stable heptyl platinum solution preparation |
| 03/09/2005 | CN1191823C Cell for producing alginate capsules |
| 03/08/2005 | US6864368 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases |
| 03/08/2005 | US6864355 Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain |
| 03/08/2005 | US6864291 Agonists specific for the peripheral cannabinoid receptor |
| 03/08/2005 | US6864286 2-cyano-3-hydroxy-p-(trifluoromethoxy)crotonanilide |
| 03/08/2005 | US6864283 Marine extracts; analogs of the spisulosine family |
| 03/08/2005 | US6864277 Brain diosrders; cardiovascular disorders; central nervous system disorders; psychological disorders |
| 03/08/2005 | US6864275 Anticancer agents; viricides |
| 03/08/2005 | US6864263 For therpay of inflammatory bowel disease, cerebral ischemia and arthritis, adult respiratory distress syndrome (ARDS) and myocarditis, as adjuvants to short term immunosuppression in transplant therapy |
| 03/08/2005 | US6864255 Substituted triazinyl amide derivatives and methods of use |
| 03/08/2005 | US6864252 Treatment of cyclooxygenase mediated diseases, such as arthritis, neurodegeneration and colon cancer |
| 03/08/2005 | US6864227 Artery-and vein-specific proteins and uses therefor |
| 03/08/2005 | US6864064 18891, a novel human lipase |
| 03/08/2005 | US6864054 Polypeptides from CREB binding protein and related protein p300 for use in transcriptional regulation |
| 03/08/2005 | US6863894 Mutant Salmonella; anticancer agents |
| 03/08/2005 | US6863647 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 03/08/2005 | US6862890 Process for production of nanoparticles and microparticles by spray freezing into liquid |
| 03/08/2005 | CA2480712A1 Chondrocyte therapeutic delivery system |
| 03/08/2005 | CA2290482C Fructan containing composition for the prevention and treatment of colon cancer |
| 03/08/2005 | CA2262776C Antitumor antisense sequences directed against r1 and r2 components of ribonucleotide reductase |
| 03/03/2005 | WO2005019464A1 Poxvirus vector encoding prostate specific antigens for treatment of prostate cancer |
| 03/03/2005 | WO2005019451A1 Nucleic acid construct for expressing pdk-1 activity inhibitor |
| 03/03/2005 | WO2005019450A1 Process for producing cytotoxic lymphocytes |
| 03/03/2005 | WO2005019441A1 Method of differentiation from embryo-stem cell of primate to hematogenous cell |
| 03/03/2005 | WO2005019269A2 Techniques and compositions for the diagnosis and treatment of cancer (muc1) |
| 03/03/2005 | WO2005019268A1 Novel antibody against cancer antigen |
| 03/03/2005 | WO2005019245A1 Heptadepsin |
| 03/03/2005 | WO2005019220A2 Substituted imidazo[1,2-a]pyrazines as modulators of kinase activity |
| 03/03/2005 | WO2005019219A1 Pyrrolopyrimidinone derivative |
| 03/03/2005 | WO2005019218A1 Pyrrolopyrimidinethione derivative |
| 03/03/2005 | WO2005019206A1 Mitotic kinesin inhibitors |
| 03/03/2005 | WO2005019205A1 Mitotic kinesin inhibitors |
| 03/03/2005 | WO2005019193A2 Phenylurea derivatives useful in the treatment of conditions mediated by polo-like kinases (plk) |
| 03/03/2005 | WO2005019192A1 Urea derivatives and their use as tyrosinkinase inhibitors |
| 03/03/2005 | WO2005019188A1 Fused pyrimidine derivative and use thereof |
| 03/03/2005 | WO2005019174A1 Acetylene derivatives as inhibitors of histone deacetylase |
| 03/03/2005 | WO2005018677A2 Use of combination of an epidermal growth factor receptor kinase inhibitor and cytotoxic agents for treatment and inhibition of cancer |
| 03/03/2005 | WO2005018674A1 Remedy for diseases associated with immunoglobulin gene translocation |
| 03/03/2005 | WO2005018671A1 Cancer metastasis inhibitor |
| 03/03/2005 | WO2005018662A1 Use of polypeptides of the cupredoxin family in cancer therapy |
| 03/03/2005 | WO2005018648A1 (20S)-1α-HYDROXY-2-METHYLENE-19-NOR-VITAMIN D3 AND ITS USES |
| 03/03/2005 | WO2005018638A1 Mitotic kinesin inhibitors |
| 03/03/2005 | WO2005018610A1 In vivo targeting of dendritic cells |
| 03/03/2005 | WO2005018580A2 Anti-cancer virus desensitization method |
| 03/03/2005 | WO2005018547A2 Mitotic kinesin inhibitors |
| 03/03/2005 | WO2004112761A3 Stable 5, 10-methylene-tetrahydrofolate pharmaceutical compounds |
| 03/03/2005 | WO2004110481A3 Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the listeria, and methods of use thereof |
| 03/03/2005 | WO2004108764A3 Connective tissue growth factor antibodies |
| 03/03/2005 | WO2004099254A3 Activation of recombinant diphtheria toxin fusion proteins by specific proteases highly expressed on the surface of tumor cells |
| 03/03/2005 | WO2004076410A3 Polymorphs of pyrrole substituted 2-indolinone protein kinase inhibitors |
| 03/03/2005 | WO2004006936A8 Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy |
| 03/03/2005 | WO2003102151A3 Modulating cell differentiation and treating myeloprolifertive disorders with jnk/mkk inhibitors |
| 03/03/2005 | WO2003078458A9 Tap-70, a novel marker for epithelial tumors |
| 03/03/2005 | WO2003031405A3 Methods for the synthesis of substituted purines |
| 03/03/2005 | US20050050589 Soya cell strains with high isoflavone content |
| 03/03/2005 | US20050050580 Transgenic animal expressing hla-a24 and utilization thereof |
| 03/03/2005 | US20050050191 Storage network and method for storage network device mapping |
| 03/03/2005 | US20050049424 6-Hydroxy isoflavones derivatives and medicaments involving same |
| 03/03/2005 | US20050049408 That retains the high RNA binding affinity of the parent oligonucleotide N3' --> P5' phosphoramidates and exhibits a much higher acid stability; inhibiting human telomerase enzyme activity; solid phase synthesis; kits |
| 03/03/2005 | US20050049303 Adamantane derivatives |
| 03/03/2005 | US20050049294 Methods of using [3.2.0] heterocyclic compounds and analogs thereof |
| 03/03/2005 | US20050049292 Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression |